Immunicon Corporation Announces Availability of Fluorescence In-Situ Hybridization Product Portfolio

Published: Apr 08, 2008

HUNTINGDON VALLEY, Pa.--(BUSINESS WIRE)--Immunicon Corporation (NASDAQ:IMMC) announced today the availability of a new product portfolio for Fluorescence In-Situ Hybridization (FISH) testing. The new RF Poseidon™ FISH Probes are available to the life science and diagnostic clinical laboratories.

Back to news